1h Free Analyst Time
Speak directly to the analyst to clarify any post sales queries you may have.
Over the past decade, the C1 esterase inhibitor market has undergone major transformation, evolving from plasma-derived infusions administered in clinical settings to innovative therapies that prioritize patient autonomy and efficiency. As new delivery mechanisms and advanced formulations emerge, market participants are rethinking both care models and commercial strategies to address the diverse needs of patients with angioedema.
Market Snapshot: C1 Esterase Inhibitor Landscape
The C1 esterase inhibitor market is marked by robust demand across hereditary and acquired angioedema management. Advances in recombinant technologies and subcutaneous delivery formats have dramatically shifted clinical practice. Improved pharmacokinetics and patient empowerment have lowered hospitalization rates and redefined market access strategy. Intense competition from biosimilars and digital health integration is also transforming patient pathways and stakeholder engagement.
Scope & Segmentation
This research examines the C1 esterase inhibitor market through comprehensive segmentation, providing actionable insights for decision-makers.
- Indication: Acquired Angioedema; Hereditary Angioedema
- Product Type: Plasma Derived; Recombinant
- Route Of Administration: Intravenous; Subcutaneous
- Distribution Channel: Hospital Pharmacy; Online Pharmacy; Retail Pharmacy
- End User: Clinics; Homecare (Professional Administration, Self Administration); Hospitals
- Dosage Form: Prefilled Syringe; Vial
- Regions: Americas (United States – California, Texas, New York, Florida, Illinois, Pennsylvania, Ohio; Canada; Mexico; Brazil; Argentina); Europe, Middle East & Africa (including United Kingdom, Germany, France, Italy, Spain, United Arab Emirates, South Africa, and more); Asia-Pacific (including China, India, Japan, Australia, South Korea, and others)
Companies analyzed include Takeda Pharmaceutical Company Limited, CSL Limited, Octapharma AG, Pharming Group N.V., Kamada Ltd., and Kedrion S.p.A.
Key Takeaways
- Therapies targeting C1 esterase are moving towards patient-centric care, with subcutaneous and self-administration options expanding beyond traditional infusion settings.
- Technological innovation, especially recombinant formulations, is driving new standards in safety, adherence, and personalization, fueling competition and product differentiation.
- Tariffs on pharmaceutical ingredients and finished biologics have reshaped supply chains, prompting manufacturers to invest strategically in domestic production and risk mitigation.
- Market access strategies depend on understanding segmentation by indication, product type, route, and patient environment to meet varied needs across healthcare systems and geographies.
- Digital platforms are facilitating remote support and adherence monitoring, while multi-stakeholder collaboration remains central to successful therapy deployment and sustainable access.
Tariff Impact: Supply Chains and Cost Structures
Recent tariff policies in the United States have introduced complexities in the C1 esterase inhibitor supply chain, particularly affecting raw material sourcing for plasma derivatives. Contract negotiations have shifted, encouraging investment in regional manufacturing and more robust contingency planning. Payer reimbursement and patient costs are influenced by these cumulative tariff effects, making transparent economic assessment and advocacy essential for stakeholders.
Methodology & Data Sources
This report utilizes a multi-layered research approach. Insights draw from qualitative interviews with clinicians and supply chain experts, as well as secondary analysis of peer-reviewed literature, regulatory filings, and industry white papers. Cross-functional stakeholder validation was undertaken to refine findings and support strategic recommendations.
Why This Report Matters
- Enables executives to navigate evolving supply chains and shifting regulatory environments with evidence-based, scenario-driven analysis.
- Guides strategies for patient engagement, digital transformation, and sustainable access through segmentation intelligence and actionable recommendations.
- Empowers product and market leaders to benchmark competitive moves and anticipate emerging innovation across regions and delivery models.
Conclusion
The C1 esterase inhibitor market reflects ongoing innovation in clinical delivery, manufacturing strategy, and ecosystem collaboration. Armed with segmentation insights and an understanding of regulatory and competitive pressures, stakeholders can position themselves for resilience and growth in this evolving therapeutic space.
This product will be delivered within 1-3 business days.
Table of Contents
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Impact of gene therapy approaches for hereditary angioedema patients and their market adoption
5.2. Expansion of subcutaneous administration options improving patient compliance and market growth
5.3. Rising off-label uses in autoimmune and transplant indications driving incremental demand growth
5.4. Development of biosimilar C1 esterase inhibitors reshaping pricing strategies and competitive landscape
5.5. Regional reimbursement policies and patient access programs shaping market uptake in emerging economies
5.6. Emergence of novel oral C1 esterase inhibitors in clinical development altering future treatment paradigms
5.7. Strategic collaborations between biotech companies and big pharma accelerating R&D efforts
5.2. Expansion of subcutaneous administration options improving patient compliance and market growth
5.3. Rising off-label uses in autoimmune and transplant indications driving incremental demand growth
5.4. Development of biosimilar C1 esterase inhibitors reshaping pricing strategies and competitive landscape
5.5. Regional reimbursement policies and patient access programs shaping market uptake in emerging economies
5.6. Emergence of novel oral C1 esterase inhibitors in clinical development altering future treatment paradigms
5.7. Strategic collaborations between biotech companies and big pharma accelerating R&D efforts
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
6.2. PESTLE Analysis
8. C1 Esterase Inhibitors Market, by Indication
8.1. Introduction
8.2. Acquired Angioedema
8.3. Hereditary Angioedema
8.2. Acquired Angioedema
8.3. Hereditary Angioedema
9. C1 Esterase Inhibitors Market, by Product Type
9.1. Introduction
9.2. Plasma Derived
9.3. Recombinant
9.2. Plasma Derived
9.3. Recombinant
10. C1 Esterase Inhibitors Market, by Route Of Administration
10.1. Introduction
10.2. Intravenous
10.3. Subcutaneous
10.2. Intravenous
10.3. Subcutaneous
11. C1 Esterase Inhibitors Market, by Distribution Channel
11.1. Introduction
11.2. Hospital Pharmacy
11.3. Online Pharmacy
11.4. Retail Pharmacy
11.2. Hospital Pharmacy
11.3. Online Pharmacy
11.4. Retail Pharmacy
12. C1 Esterase Inhibitors Market, by End User
12.1. Introduction
12.2. Clinics
12.3. Homecare
12.3.1. Professional Administration
12.3.2. Self Administration
12.4. Hospitals
12.2. Clinics
12.3. Homecare
12.3.1. Professional Administration
12.3.2. Self Administration
12.4. Hospitals
13. C1 Esterase Inhibitors Market, by Dosage Form
13.1. Introduction
13.2. Prefilled Syringe
13.3. Vial
13.2. Prefilled Syringe
13.3. Vial
14. Americas C1 Esterase Inhibitors Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa C1 Esterase Inhibitors Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific C1 Esterase Inhibitors Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Takeda Pharmaceutical Company Limited
17.3.2. CSL Limited
17.3.3. Octapharma AG
17.3.4. Pharming Group N.V.
17.3.5. Kamada Ltd.
17.3.6. Kedrion S.p.A.
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Takeda Pharmaceutical Company Limited
17.3.2. CSL Limited
17.3.3. Octapharma AG
17.3.4. Pharming Group N.V.
17.3.5. Kamada Ltd.
17.3.6. Kedrion S.p.A.
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. C1 ESTERASE INHIBITORS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL C1 ESTERASE INHIBITORS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL C1 ESTERASE INHIBITORS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL C1 ESTERASE INHIBITORS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL C1 ESTERASE INHIBITORS MARKET SIZE, BY INDICATION, 2024 VS 2030 (%)
FIGURE 6. GLOBAL C1 ESTERASE INHIBITORS MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL C1 ESTERASE INHIBITORS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL C1 ESTERASE INHIBITORS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL C1 ESTERASE INHIBITORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL C1 ESTERASE INHIBITORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL C1 ESTERASE INHIBITORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL C1 ESTERASE INHIBITORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL C1 ESTERASE INHIBITORS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL C1 ESTERASE INHIBITORS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL C1 ESTERASE INHIBITORS MARKET SIZE, BY DOSAGE FORM, 2024 VS 2030 (%)
FIGURE 16. GLOBAL C1 ESTERASE INHIBITORS MARKET SIZE, BY DOSAGE FORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS C1 ESTERASE INHIBITORS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS C1 ESTERASE INHIBITORS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES C1 ESTERASE INHIBITORS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES C1 ESTERASE INHIBITORS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA C1 ESTERASE INHIBITORS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA C1 ESTERASE INHIBITORS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC C1 ESTERASE INHIBITORS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC C1 ESTERASE INHIBITORS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. C1 ESTERASE INHIBITORS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. C1 ESTERASE INHIBITORS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 27. C1 ESTERASE INHIBITORS MARKET: RESEARCHAI
FIGURE 28. C1 ESTERASE INHIBITORS MARKET: RESEARCHSTATISTICS
FIGURE 29. C1 ESTERASE INHIBITORS MARKET: RESEARCHCONTACTS
FIGURE 30. C1 ESTERASE INHIBITORS MARKET: RESEARCHARTICLES
FIGURE 2. GLOBAL C1 ESTERASE INHIBITORS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL C1 ESTERASE INHIBITORS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL C1 ESTERASE INHIBITORS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL C1 ESTERASE INHIBITORS MARKET SIZE, BY INDICATION, 2024 VS 2030 (%)
FIGURE 6. GLOBAL C1 ESTERASE INHIBITORS MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL C1 ESTERASE INHIBITORS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL C1 ESTERASE INHIBITORS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL C1 ESTERASE INHIBITORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL C1 ESTERASE INHIBITORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL C1 ESTERASE INHIBITORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL C1 ESTERASE INHIBITORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL C1 ESTERASE INHIBITORS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL C1 ESTERASE INHIBITORS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL C1 ESTERASE INHIBITORS MARKET SIZE, BY DOSAGE FORM, 2024 VS 2030 (%)
FIGURE 16. GLOBAL C1 ESTERASE INHIBITORS MARKET SIZE, BY DOSAGE FORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS C1 ESTERASE INHIBITORS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS C1 ESTERASE INHIBITORS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES C1 ESTERASE INHIBITORS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES C1 ESTERASE INHIBITORS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA C1 ESTERASE INHIBITORS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA C1 ESTERASE INHIBITORS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC C1 ESTERASE INHIBITORS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC C1 ESTERASE INHIBITORS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. C1 ESTERASE INHIBITORS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. C1 ESTERASE INHIBITORS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 27. C1 ESTERASE INHIBITORS MARKET: RESEARCHAI
FIGURE 28. C1 ESTERASE INHIBITORS MARKET: RESEARCHSTATISTICS
FIGURE 29. C1 ESTERASE INHIBITORS MARKET: RESEARCHCONTACTS
FIGURE 30. C1 ESTERASE INHIBITORS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. C1 ESTERASE INHIBITORS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL C1 ESTERASE INHIBITORS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL C1 ESTERASE INHIBITORS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL C1 ESTERASE INHIBITORS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL C1 ESTERASE INHIBITORS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL C1 ESTERASE INHIBITORS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL C1 ESTERASE INHIBITORS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL C1 ESTERASE INHIBITORS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL C1 ESTERASE INHIBITORS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL C1 ESTERASE INHIBITORS MARKET SIZE, BY ACQUIRED ANGIOEDEMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL C1 ESTERASE INHIBITORS MARKET SIZE, BY ACQUIRED ANGIOEDEMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL C1 ESTERASE INHIBITORS MARKET SIZE, BY HEREDITARY ANGIOEDEMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL C1 ESTERASE INHIBITORS MARKET SIZE, BY HEREDITARY ANGIOEDEMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL C1 ESTERASE INHIBITORS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL C1 ESTERASE INHIBITORS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL C1 ESTERASE INHIBITORS MARKET SIZE, BY PLASMA DERIVED, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL C1 ESTERASE INHIBITORS MARKET SIZE, BY PLASMA DERIVED, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL C1 ESTERASE INHIBITORS MARKET SIZE, BY RECOMBINANT, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL C1 ESTERASE INHIBITORS MARKET SIZE, BY RECOMBINANT, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL C1 ESTERASE INHIBITORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL C1 ESTERASE INHIBITORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL C1 ESTERASE INHIBITORS MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL C1 ESTERASE INHIBITORS MARKET SIZE, BY INTRAVENOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL C1 ESTERASE INHIBITORS MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL C1 ESTERASE INHIBITORS MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL C1 ESTERASE INHIBITORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL C1 ESTERASE INHIBITORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL C1 ESTERASE INHIBITORS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL C1 ESTERASE INHIBITORS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL C1 ESTERASE INHIBITORS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL C1 ESTERASE INHIBITORS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL C1 ESTERASE INHIBITORS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL C1 ESTERASE INHIBITORS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL C1 ESTERASE INHIBITORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL C1 ESTERASE INHIBITORS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL C1 ESTERASE INHIBITORS MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL C1 ESTERASE INHIBITORS MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL C1 ESTERASE INHIBITORS MARKET SIZE, BY HOMECARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL C1 ESTERASE INHIBITORS MARKET SIZE, BY HOMECARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL C1 ESTERASE INHIBITORS MARKET SIZE, BY PROFESSIONAL ADMINISTRATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL C1 ESTERASE INHIBITORS MARKET SIZE, BY PROFESSIONAL ADMINISTRATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL C1 ESTERASE INHIBITORS MARKET SIZE, BY SELF ADMINISTRATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL C1 ESTERASE INHIBITORS MARKET SIZE, BY SELF ADMINISTRATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL C1 ESTERASE INHIBITORS MARKET SIZE, BY HOMECARE, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL C1 ESTERASE INHIBITORS MARKET SIZE, BY HOMECARE, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL C1 ESTERASE INHIBITORS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL C1 ESTERASE INHIBITORS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL C1 ESTERASE INHIBITORS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL C1 ESTERASE INHIBITORS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL C1 ESTERASE INHIBITORS MARKET SIZE, BY PREFILLED SYRINGE, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL C1 ESTERASE INHIBITORS MARKET SIZE, BY PREFILLED SYRINGE, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL C1 ESTERASE INHIBITORS MARKET SIZE, BY VIAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL C1 ESTERASE INHIBITORS MARKET SIZE, BY VIAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. AMERICAS C1 ESTERASE INHIBITORS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 56. AMERICAS C1 ESTERASE INHIBITORS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 57. AMERICAS C1 ESTERASE INHIBITORS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 58. AMERICAS C1 ESTERASE INHIBITORS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 59. AMERICAS C1 ESTERASE INHIBITORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 60. AMERICAS C1 ESTERASE INHIBITORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 61. AMERICAS C1 ESTERASE INHIBITORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 62. AMERICAS C1 ESTERASE INHIBITORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 63. AMERICAS C1 ESTERASE INHIBITORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 64. AMERICAS C1 ESTERASE INHIBITORS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 65. AMERICAS C1 ESTERASE INHIBITORS MARKET SIZE, BY HOMECARE, 2018-2024 (USD MILLION)
TABLE 66. AMERICAS C1 ESTERASE INHIBITORS MARKET SIZE, BY HOMECARE, 2025-2030 (USD MILLION)
TABLE 67. AMERICAS C1 ESTERASE INHIBITORS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 68. AMERICAS C1 ESTERASE INHIBITORS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 69. AMERICAS C1 ESTERASE INHIBITORS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 70. AMERICAS C1 ESTERASE INHIBITORS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 71. UNITED STATES C1 ESTERASE INHIBITORS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 72. UNITED STATES C1 ESTERASE INHIBITORS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 73. UNITED STATES C1 ESTERASE INHIBITORS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 74. UNITED STATES C1 ESTERASE INHIBITORS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 75. UNITED STATES C1 ESTERASE INHIBITORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 76. UNITED STATES C1 ESTERASE INHIBITORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 77. UNITED STATES C1 ESTERASE INHIBITORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 78. UNITED STATES C1 ESTERASE INHIBITORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 79. UNITED STATES C1 ESTERASE INHIBITORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 80. UNITED STATES C1 ESTERASE INHIBITORS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 81. UNITED STATES C1 ESTERASE INHIBITORS MARKET SIZE, BY HOMECARE, 2018-2024 (USD MILLION)
TABLE 82. UNITED STATES C1 ESTERASE INHIBITORS MARKET SIZE, BY HOMECARE, 2025-2030 (USD MILLION)
TABLE 83. UNITED STATES C1 ESTERASE INHIBITORS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 84. UNITED STATES C1 ESTERASE INHIBITORS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 85. UNITED STATES C1 ESTERASE INHIBITORS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 86. UNITED STATES C1 ESTERASE INHIBITORS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 87. CANADA C1 ESTERASE INHIBITORS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 88. CANADA C1 ESTERASE INHIBITORS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 89. CANADA C1 ESTERASE INHIBITORS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 90. CANADA C1 ESTERASE INHIBITORS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 91. CANADA C1 ESTERASE INHIBITORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 92. CANADA C1 ESTERASE INHIBITORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 93. CANADA C1 ESTERASE INHIBITORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 94. CANADA C1 ESTERASE INHIBITORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 95. CANADA C1 ESTERASE INHIBITORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 96. CANADA C1 ESTERASE INHIBITORS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 97. CANADA C1 ESTERASE INHIBITORS MARKET SIZE, BY HOMECARE, 2018-2024 (USD MILLION)
TABLE 98. CANADA C1 ESTERASE INHIBITORS MARKET SIZE, BY HOMECARE, 2025-2030 (USD MILLION)
TABLE 99. CANADA C1 ESTERASE INHIBITORS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 100. CANADA C1 ESTERASE INHIBITORS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 101. MEXICO C1 ESTERASE INHIBITORS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 102. MEXICO C1 ESTERASE INHIBITORS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 103. MEXICO C1 ESTERASE INHIBITORS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 104. MEXICO C1 ESTERASE INHIBITORS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 105. MEXICO C1 ESTERASE INHIBITORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 106. MEXICO C1 ESTERASE INHIBITORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 107. MEXICO C1 ESTERASE INHIBITORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 108. MEXICO C1 ESTERASE INHIBITORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 109. MEXICO C1 ESTERASE INHIBITORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 110. MEXICO C1 ESTERASE INHIBITORS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 111. MEXICO C1 ESTERASE INHIBITORS MARKET SIZE, BY HOMECARE, 2018-2024 (USD MILLION)
TABLE 112. MEXICO C1 ESTERASE INHIBITORS MARKET SIZE, BY HOMECARE, 2025-2030 (USD MILLION)
TABLE 113. MEXICO C1 ESTERASE INHIBITORS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 114. MEXICO C1 ESTERASE INHIBITORS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 115. BRAZIL C1 ESTERASE INHIBITORS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 116. BRAZIL C1 ESTERASE INHIBITORS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 117. BRAZIL C1 ESTERASE INHIBITORS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 118. BRAZIL C1 ESTERASE INHIBITORS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 119. BRAZIL C1 ESTERASE INHIBITORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 120. BRAZIL C1 ESTERASE INHIBITORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 121. BRAZIL C1 ESTERASE INHIBITORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 122. BRAZIL C1 ESTERASE INHIBITORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 123. BRAZIL C1 ESTERASE INHIBITORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 124. BRAZIL C1 ESTERASE INHIBITORS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 125. BRAZIL C1 ESTERASE INHIBITORS MARKET SIZE, BY HOMECARE, 2018-2024 (USD MILLION)
TABLE 126. BRAZIL C1 ESTERASE INHIBITORS MARKET SIZE, BY HOMECARE, 2025-2030 (USD MILLION)
TABLE 127. BRAZIL C1 ESTERASE INHIBITORS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 128. BRAZIL C1 ESTERASE INHIBITORS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 129. ARGENTINA C1 ESTERASE INHIBITORS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 130. ARGENTINA C1 ESTERASE INHIBITORS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 131. ARGENTINA C1 ESTERASE INHIBITORS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 132. ARGENTINA C1 ESTERASE INHIBITORS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 133. ARGENTINA C1 ESTERASE INHIBITORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 134. ARGENTINA C1 ESTERASE INHIBITORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 135. ARGENTINA C1 ESTERASE INHIBITORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 136. ARGENTINA C1 ESTERASE INHIBITORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 137. ARGENTINA C1 ESTERASE INHIBITORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 138. ARGENTINA C1 ESTERASE INHIBITORS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 139. ARGENTINA C1 ESTERASE INHIBITORS MARKET SIZE, BY HOMECARE, 2018-2024 (USD MILLION)
TABLE 140. ARGENTINA C1 ESTERASE INHIBITORS MARKET SIZE, BY HOMECARE, 2025-2030 (USD MILLION)
TABLE 141. ARGENTINA C1 ESTERASE INHIBITORS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 142. ARGENTINA C1 ESTERASE INHIBITORS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 143. EUROPE, MIDDLE EAST & AFRICA C1 ESTERASE INHIBITORS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 144. EUROPE, MIDDLE EAST & AFRICA C1 ESTERASE INHIBITORS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 145. EUROPE, MIDDLE EAST & AFRICA C1 ESTERASE INHIBITORS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 146. EUROPE, MIDDLE EAST & AFRICA C1 ESTERASE INHIBITORS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 147. EUROPE, MIDDLE EAST & AFRICA C1 ESTERASE INHIBITORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 148. EUROPE, MIDDLE EAST & AFRICA C1 ESTERASE INHIBITORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 149. EUROPE, MIDDLE EAST & AFRICA C1 ESTERASE INHIBITORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 150. EUROPE, MIDDLE EAST & AFRICA C1 ESTERASE INHIBITORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA C1 ESTERASE INHIBITORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 152. EUROPE, MIDDLE EAST & AFRICA C1 ESTERASE INHIBITORS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 153. EUROPE, MIDDLE EAST & AFRICA C1 ESTERASE INHIBITORS MARKET SIZE, BY HOMECARE, 2018-2024 (USD MILLION)
TABLE 154. EUROPE, MIDDLE EAST & AFRICA C1 ESTERASE INHIBITORS MARKET SIZE, BY HOMECARE, 2025-2030 (USD MILLION)
TABLE 155. EUROPE, MIDDLE EAST & AFRICA C1 ESTERASE INHIBITORS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 156. EUROPE, MIDDLE EAST & AFRICA C1 ESTERASE INHIBITORS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 157. EUROPE, MIDDLE EAST & AFRICA C1 ESTERASE INHIBITORS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 158. EUROPE, MIDDLE EAST & AFRICA C1 ESTERASE INHIBITORS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 159. UNITED KINGDOM C1 ESTERASE INHIBITORS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 160. UNITED KINGDOM C1 ESTERASE INHIBITORS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 161. UNITED KINGDOM C1 ESTERASE INHIBITORS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 162. UNITED KINGDOM C1 ESTERASE INHIBITORS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 163. UNITED KINGDOM C1 ESTERASE INHIBITORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 164. UNITED KINGDOM C1 ESTERASE INHIBITORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 165. UNITED KINGDOM C1 ESTERASE INHIBITORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 166. UNITED KINGDOM C1 ESTERASE INHIBITORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 167. UNITED KINGDOM C1 ESTERASE INHIBITORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 168. UNITED KINGDOM C1 ESTERASE INHIBITORS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 169. UNITED KINGDOM C1 ESTERASE INHIBITORS MARKET SIZE, BY HOMECARE, 2018-2024 (USD MILLION)
TABLE 170. UNITED KINGDOM C1 ESTERASE INHIBITORS MARKET SIZE, BY HOMECARE, 2025-2030 (USD MILLION)
TABLE 171. UNITED KINGDOM C1 ESTERASE INHIBITORS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 172. UNITED KINGDOM C1 ESTERASE INHIBITORS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 173. GERMANY C1 ESTERASE INHIBITORS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 174. GERMANY C1 ESTERASE INHIBITORS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 175. GERMANY C1 ESTERASE INHIBITORS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 176. GERMANY C1 ESTERASE INHIBITORS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 177. GERMANY C1 ESTERASE INHIBITORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 178. GERMANY C1 ESTERASE INHIBITORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 179. GERMANY C1 ESTERASE INHIBITORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 180. GERMANY C1 ESTERASE INHIBITORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 181. GERMANY C1 ESTERASE INHIBITORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 182. GERMANY C1 ESTERASE INHIBITORS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 183. GERMANY C1 ESTERASE INHIBITORS MARKET SIZE, BY HOMECARE, 2018-2024 (USD MILLION)
TABLE 184. GERMANY C1 ESTERASE INHIBITORS MARKET SIZE, BY HOMECARE, 2025-2030 (USD MILLION)
TABLE 185. GERMANY C1 ESTERASE INHIBITORS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 186. GERMANY C1 ESTERASE INHIBITORS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 187. FRANCE C1 ESTERASE INHIBITORS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 188. FRANCE C1 ESTERASE INHIBITORS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 189. FRANCE C1 ESTERASE INHIBITORS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 190. FRANCE C1 ESTERASE INHIBITORS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 191. FRANCE C1 ESTERASE INHIBITORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 192. FRANCE C1 ESTERASE INHIBITORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 193. FRANCE C1 ESTERASE INHIBITORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 194. FRANCE C1 ESTERASE INHIBITORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 195. FRANCE C1 ESTERASE INHIBITORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 196. FRANCE C1 ESTERASE INHIBITORS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 197. FRANCE C1 ESTERASE INHIBITORS MARKET SIZE, BY HOMECARE, 2018-2024 (USD MILLION)
TABLE 198. FRANCE C1 ESTERASE INHIBITORS MARKET SIZE, BY HOMECARE, 2025-2030 (USD MILLION)
TABLE 199. FRANCE C1 ESTERASE INHIBITORS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 200. FRANCE C1 ESTERASE INHIBITORS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 201. RUSSIA C1 ESTERASE INHIBITORS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 202. RUSSIA C1 ESTERASE INHIBITORS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 203. RUSSIA C1 ESTERASE INHIBITORS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 204. RUSSIA C1 ESTERASE INHIBITORS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 205. RUSSIA C1 ESTERASE INHIBITORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 206. RUSSIA C1 ESTERASE INHIBITORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 207. RUSSIA C1 ESTERASE INHIBITORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 208. RUSSIA C1 ESTERASE INHIBITORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 209. RUSSIA C1 ESTERASE INHIBITORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 210. RUSSIA C1 ESTERASE INHIBITORS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 211. RUSSIA C1 ESTERASE INHIBITORS MARKET SIZE, BY HOMECARE, 2018-2024 (USD MILLION)
TABLE 212. RUSSIA C1 ESTERASE INHIBITORS MARKET SIZE, BY HOMECARE, 2025-2030 (USD MILLION)
TABLE 213. RUSSIA C1 ESTERASE INHIBITORS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 214. RUSSIA C1 ESTERASE INHIBITORS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 215. ITALY C1 ESTERASE INHIBITORS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 216. ITALY C1 ESTERASE INHIBITORS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 217. ITALY C1 ESTERASE INHIBITORS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 218. ITALY C1 ESTERASE INHIBITORS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 219. ITALY C1 ESTERASE INHIBITORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 220. ITALY C1 ESTERASE INHIBITORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 221. ITALY C1 ESTERASE INHIBITORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 222. ITALY C1 ESTERASE INHIBITORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 223. ITALY C1 ESTERASE INHIBITORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 224. ITALY C1 ESTERASE INHIBITORS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 225. ITALY C1 ESTERASE INHIBITORS MARKET SIZE, BY HOMECARE, 2018-2024 (USD MILLION)
TABLE 226. ITALY C1 ESTERASE INHIBITORS MARKET SIZE, BY HOMECARE, 2025-2030 (USD MILLION)
TABLE 227. ITALY C1 ESTERASE INHIBITORS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 228. ITALY C1 ESTERASE INHIBITORS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 229. SPAIN C1 ESTERASE INHIBITORS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 230. SPAIN C1 ESTERASE INHIBITORS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 231. SPAIN C1 ESTERASE INHIBITORS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 232. SPAIN C1 ESTERASE INHIBITORS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 233. SPAIN C1 ESTERASE INHIBITORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 234. SPAIN C1 ESTERASE INHIBITORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 235. SPAIN C1 ESTERASE INHIBITORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 236. SPAIN C1 ESTERASE INHIBITORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 237. SPAIN C1 ESTERASE INHIBITORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 238. SPAIN C1 ESTERASE INHIBITORS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 239. SPAIN C1 ESTERASE INHIBITORS MARKET SIZE, BY HOMECARE, 2018-2024 (USD MILLION)
TABLE 240. SPAIN C1 ESTERASE INHIBITORS MARKET SIZE, BY HOMECARE, 2025-2030 (USD MILLION)
TABLE 241. SPAIN C1 ESTERASE INHIBITORS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 242. SPAIN C1 ESTERASE INHIBITORS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 243. UNITED ARAB EMIRATES C1 ESTERASE INHIBITORS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 244. UNITED ARAB EMIRATES C1 ESTERASE INHIBITORS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 245. UNITED ARAB EMIRATES C1 ESTERASE INHIBITORS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 246. UNITED ARAB EMIRATES C1 ESTERASE INHIBITORS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 247. UNITED ARAB EMIRATES C1 ESTERASE INHIBITORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 248. UNITED ARAB EMIRATES C1 ESTERASE INHIBITORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 249. UNITED ARAB EMIRATES C1 ESTERASE INHIBITORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 250. UNITED ARAB EMIRATES C1 ESTERASE INHIBITORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 251. UNITED ARAB EMIRATES C1 ESTERASE INHIBITORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 252. UNITED ARAB EMIRATES C1 ESTERASE INHIBITORS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 253. UNITED ARAB EMIRATES C1 ESTERASE INHIBITORS MARKET SIZE, BY HOMECARE, 2018-2024 (USD MILLION)
TABLE 254. UNITED ARAB EMIRATES C1 ESTERASE INHIBITORS MARKET SIZE, BY HOMECARE, 2025-2030 (USD MILLION)
TABLE 255. UNITED ARAB EMIRATES C1 ESTERASE INHIBITORS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 256. UNITED ARAB EMIRATES C1 ESTERASE INHIBITORS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 257. SAUDI ARABIA C1 ESTERASE INHIBITORS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 258. SAUDI ARABIA C1 ESTERASE INHIBITORS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 259. SAUDI ARABIA C1 ESTERASE INHIBITORS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 260. SAUDI ARABIA C1 ESTERASE INHIBITORS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 261. SAUDI ARABIA C1 ESTERASE INHIBITORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 262. SAUDI ARABIA C1 ESTERASE INHIBITORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 263. SAUDI ARABIA C1 ESTERASE INHIBITORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 264. SAUDI ARABIA C1 ESTERASE INHIBITORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 265. SAUDI ARABIA C1 ESTERASE INHIBITORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 266. SAUDI ARABIA C1 ESTERASE INHIBITORS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 267. SAUDI ARABIA C1 ESTERASE INHIBITORS MARKET SIZE, BY HOMECARE, 2018-2024 (USD MILLION)
TABLE 268. SAUDI ARABIA C1 ESTERASE INHIBITORS MARKET SIZE, BY HOMECARE, 2025-2030 (USD MILLION)
TABLE 269. SAUDI ARABIA C1 ESTERASE INHIBITORS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 270. SAUDI ARABIA C1 ESTERASE INHIBITORS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 271. SOUTH AFRICA C1 ESTERASE INHIBITORS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 272. SOUTH AFRICA C1 ESTERASE INHIBITORS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 273. SOUTH AFRICA C1 ESTERASE INHIBITORS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 274. SOUTH AFRICA C1 ESTERASE INHIBITORS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 275. SOUTH AFRICA C1 ESTERASE INHIBITORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 276. SOUTH AFRICA C1 ESTERASE INHIBITORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 277. SOUTH AFRICA C1 ESTERASE INHIBITORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 278. SOUTH AFRICA C1 ESTERASE INHIBITORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 279. SOUTH AFRICA C1 ESTERASE INHIBITORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 280. SOUTH AFRICA C1 ESTERASE INHIBITORS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 281. SOUTH AFRICA C1 ESTERASE INHIBITORS MARKET SIZE, BY HOMECARE, 2018-2024 (USD MILLION)
TABLE 282. SOUTH AFRICA C1 ESTERASE INHIBITORS MARKET SIZE, BY HOMECARE, 2025-2030 (USD MILLION)
TABLE 283. SOUTH AFRICA C1 ESTERASE INHIBITORS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 284. SOUTH AFRICA C1 ESTERASE INHIBITORS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 285. DENMARK C1 ESTERASE INHIBITORS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 286. DENMARK C1 ESTERASE INHIBITORS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 287. DENMARK C1 ESTERASE INHIBITORS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 288. DENMARK C1 ESTERASE INHIBITORS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 289. DENMARK C1 ESTERASE INHIBITORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 290. DENMARK C1 ESTERASE INHIBITORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 291. DENMARK C1 ESTERASE INHIBITORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 292. DENMARK C1 ESTERASE INHIBITORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 293. DENMARK C1 ESTERASE INHIBITORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 294. DENMARK C1 ESTERASE INHIBITORS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 295. DENMARK C1 ESTERASE INHIBITORS MARKET SIZE, BY HOMECARE, 2018-2024 (USD MILLION)
TABLE 296. DENMARK C1 ESTERASE INHIBITORS MARKET SIZE, BY HOMECARE, 2025-2030 (USD MILLION)
TABLE 297. DENMARK C1 ESTERASE INHIBITORS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 298. DENMARK C1 ESTERASE INHIBITORS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 299. NETHERLANDS C1 ESTERASE INHIBITORS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 300. NETHERLANDS C1 ESTERASE INHIBITORS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 301. NETHERLANDS C1 ESTERASE INHIBITORS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 302. NETHERLANDS C1 ESTERASE INHIBITORS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 303. NETHERLANDS C1 ESTERASE INHIBITORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 304. NETHERLANDS C1 ESTERASE INHIBITORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 305. NETHERLANDS C1 ESTERASE INHIBITORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 306. NETHERLANDS C1 ESTERASE INHIBITORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 307. NETHERLANDS C1 ESTERASE INHIBITORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 308. NETHERLANDS C1 ESTERASE INHIBITORS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 309. NETHERLANDS C1 ESTERASE INHIBITORS MARKET SIZE, BY HOMECARE, 2018-2024 (USD MILLION)
TABLE 310. NETHERLANDS C1 ESTERASE INHIBITORS MARKET SIZE, BY HOMECARE, 2025-2030 (USD MILLION)
TABLE 311. NETHERLANDS C1 ESTERASE INHIBITORS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 312. NETHERLANDS C1 ESTERASE INHIBITORS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 313. QATAR C1 ESTERASE INHIBITORS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 314. QATAR C1 ESTERASE INHIBITORS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 315. QATAR C1 ESTERASE INHIBITORS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 316. QATAR C1 ESTERASE INHIBITORS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 317. QATAR C1 ESTERASE INHIBITORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 318. QATAR C1 ESTERASE INHIBITORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 319. QATAR C1 ESTERASE INHIBITORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 320. QATAR C1 ESTERASE INHIBITORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 321. QATAR C1 ESTERASE INHIBITORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 322. QATAR C1 ESTERASE INHIBITORS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 323. QATAR C1 ESTERASE INHIBITORS MARKET SIZE, BY HOMECARE, 2018-2024 (USD MILLION)
TABLE 324. QATAR C1 ESTERASE INHIBITORS MARKET SIZE, BY HOMECARE, 2025-2030 (USD MILLION)
TABLE 325. QATAR C1 ESTERASE INHIBITORS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 326. QATAR C1 ESTERASE INHIBITORS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 327. FINLAND C1 ESTERASE INHIBITORS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 328. FINLAND C1 ESTERASE INHIBITORS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 329. FINLAND C1 ESTERASE INHIBITORS MARKET SIZE, BY PRODU
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL C1 ESTERASE INHIBITORS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL C1 ESTERASE INHIBITORS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL C1 ESTERASE INHIBITORS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL C1 ESTERASE INHIBITORS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL C1 ESTERASE INHIBITORS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL C1 ESTERASE INHIBITORS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL C1 ESTERASE INHIBITORS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL C1 ESTERASE INHIBITORS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL C1 ESTERASE INHIBITORS MARKET SIZE, BY ACQUIRED ANGIOEDEMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL C1 ESTERASE INHIBITORS MARKET SIZE, BY ACQUIRED ANGIOEDEMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL C1 ESTERASE INHIBITORS MARKET SIZE, BY HEREDITARY ANGIOEDEMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL C1 ESTERASE INHIBITORS MARKET SIZE, BY HEREDITARY ANGIOEDEMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL C1 ESTERASE INHIBITORS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL C1 ESTERASE INHIBITORS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL C1 ESTERASE INHIBITORS MARKET SIZE, BY PLASMA DERIVED, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL C1 ESTERASE INHIBITORS MARKET SIZE, BY PLASMA DERIVED, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL C1 ESTERASE INHIBITORS MARKET SIZE, BY RECOMBINANT, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL C1 ESTERASE INHIBITORS MARKET SIZE, BY RECOMBINANT, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL C1 ESTERASE INHIBITORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL C1 ESTERASE INHIBITORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL C1 ESTERASE INHIBITORS MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL C1 ESTERASE INHIBITORS MARKET SIZE, BY INTRAVENOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL C1 ESTERASE INHIBITORS MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL C1 ESTERASE INHIBITORS MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL C1 ESTERASE INHIBITORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL C1 ESTERASE INHIBITORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL C1 ESTERASE INHIBITORS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL C1 ESTERASE INHIBITORS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL C1 ESTERASE INHIBITORS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL C1 ESTERASE INHIBITORS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL C1 ESTERASE INHIBITORS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL C1 ESTERASE INHIBITORS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL C1 ESTERASE INHIBITORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL C1 ESTERASE INHIBITORS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL C1 ESTERASE INHIBITORS MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL C1 ESTERASE INHIBITORS MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL C1 ESTERASE INHIBITORS MARKET SIZE, BY HOMECARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL C1 ESTERASE INHIBITORS MARKET SIZE, BY HOMECARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL C1 ESTERASE INHIBITORS MARKET SIZE, BY PROFESSIONAL ADMINISTRATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL C1 ESTERASE INHIBITORS MARKET SIZE, BY PROFESSIONAL ADMINISTRATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL C1 ESTERASE INHIBITORS MARKET SIZE, BY SELF ADMINISTRATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL C1 ESTERASE INHIBITORS MARKET SIZE, BY SELF ADMINISTRATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL C1 ESTERASE INHIBITORS MARKET SIZE, BY HOMECARE, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL C1 ESTERASE INHIBITORS MARKET SIZE, BY HOMECARE, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL C1 ESTERASE INHIBITORS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL C1 ESTERASE INHIBITORS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL C1 ESTERASE INHIBITORS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL C1 ESTERASE INHIBITORS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL C1 ESTERASE INHIBITORS MARKET SIZE, BY PREFILLED SYRINGE, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL C1 ESTERASE INHIBITORS MARKET SIZE, BY PREFILLED SYRINGE, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL C1 ESTERASE INHIBITORS MARKET SIZE, BY VIAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL C1 ESTERASE INHIBITORS MARKET SIZE, BY VIAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. AMERICAS C1 ESTERASE INHIBITORS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 56. AMERICAS C1 ESTERASE INHIBITORS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 57. AMERICAS C1 ESTERASE INHIBITORS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 58. AMERICAS C1 ESTERASE INHIBITORS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 59. AMERICAS C1 ESTERASE INHIBITORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 60. AMERICAS C1 ESTERASE INHIBITORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 61. AMERICAS C1 ESTERASE INHIBITORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 62. AMERICAS C1 ESTERASE INHIBITORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 63. AMERICAS C1 ESTERASE INHIBITORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 64. AMERICAS C1 ESTERASE INHIBITORS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 65. AMERICAS C1 ESTERASE INHIBITORS MARKET SIZE, BY HOMECARE, 2018-2024 (USD MILLION)
TABLE 66. AMERICAS C1 ESTERASE INHIBITORS MARKET SIZE, BY HOMECARE, 2025-2030 (USD MILLION)
TABLE 67. AMERICAS C1 ESTERASE INHIBITORS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 68. AMERICAS C1 ESTERASE INHIBITORS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 69. AMERICAS C1 ESTERASE INHIBITORS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 70. AMERICAS C1 ESTERASE INHIBITORS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 71. UNITED STATES C1 ESTERASE INHIBITORS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 72. UNITED STATES C1 ESTERASE INHIBITORS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 73. UNITED STATES C1 ESTERASE INHIBITORS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 74. UNITED STATES C1 ESTERASE INHIBITORS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 75. UNITED STATES C1 ESTERASE INHIBITORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 76. UNITED STATES C1 ESTERASE INHIBITORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 77. UNITED STATES C1 ESTERASE INHIBITORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 78. UNITED STATES C1 ESTERASE INHIBITORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 79. UNITED STATES C1 ESTERASE INHIBITORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 80. UNITED STATES C1 ESTERASE INHIBITORS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 81. UNITED STATES C1 ESTERASE INHIBITORS MARKET SIZE, BY HOMECARE, 2018-2024 (USD MILLION)
TABLE 82. UNITED STATES C1 ESTERASE INHIBITORS MARKET SIZE, BY HOMECARE, 2025-2030 (USD MILLION)
TABLE 83. UNITED STATES C1 ESTERASE INHIBITORS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 84. UNITED STATES C1 ESTERASE INHIBITORS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 85. UNITED STATES C1 ESTERASE INHIBITORS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 86. UNITED STATES C1 ESTERASE INHIBITORS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 87. CANADA C1 ESTERASE INHIBITORS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 88. CANADA C1 ESTERASE INHIBITORS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 89. CANADA C1 ESTERASE INHIBITORS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 90. CANADA C1 ESTERASE INHIBITORS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 91. CANADA C1 ESTERASE INHIBITORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 92. CANADA C1 ESTERASE INHIBITORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 93. CANADA C1 ESTERASE INHIBITORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 94. CANADA C1 ESTERASE INHIBITORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 95. CANADA C1 ESTERASE INHIBITORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 96. CANADA C1 ESTERASE INHIBITORS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 97. CANADA C1 ESTERASE INHIBITORS MARKET SIZE, BY HOMECARE, 2018-2024 (USD MILLION)
TABLE 98. CANADA C1 ESTERASE INHIBITORS MARKET SIZE, BY HOMECARE, 2025-2030 (USD MILLION)
TABLE 99. CANADA C1 ESTERASE INHIBITORS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 100. CANADA C1 ESTERASE INHIBITORS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 101. MEXICO C1 ESTERASE INHIBITORS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 102. MEXICO C1 ESTERASE INHIBITORS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 103. MEXICO C1 ESTERASE INHIBITORS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 104. MEXICO C1 ESTERASE INHIBITORS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 105. MEXICO C1 ESTERASE INHIBITORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 106. MEXICO C1 ESTERASE INHIBITORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 107. MEXICO C1 ESTERASE INHIBITORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 108. MEXICO C1 ESTERASE INHIBITORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 109. MEXICO C1 ESTERASE INHIBITORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 110. MEXICO C1 ESTERASE INHIBITORS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 111. MEXICO C1 ESTERASE INHIBITORS MARKET SIZE, BY HOMECARE, 2018-2024 (USD MILLION)
TABLE 112. MEXICO C1 ESTERASE INHIBITORS MARKET SIZE, BY HOMECARE, 2025-2030 (USD MILLION)
TABLE 113. MEXICO C1 ESTERASE INHIBITORS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 114. MEXICO C1 ESTERASE INHIBITORS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 115. BRAZIL C1 ESTERASE INHIBITORS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 116. BRAZIL C1 ESTERASE INHIBITORS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 117. BRAZIL C1 ESTERASE INHIBITORS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 118. BRAZIL C1 ESTERASE INHIBITORS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 119. BRAZIL C1 ESTERASE INHIBITORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 120. BRAZIL C1 ESTERASE INHIBITORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 121. BRAZIL C1 ESTERASE INHIBITORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 122. BRAZIL C1 ESTERASE INHIBITORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 123. BRAZIL C1 ESTERASE INHIBITORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 124. BRAZIL C1 ESTERASE INHIBITORS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 125. BRAZIL C1 ESTERASE INHIBITORS MARKET SIZE, BY HOMECARE, 2018-2024 (USD MILLION)
TABLE 126. BRAZIL C1 ESTERASE INHIBITORS MARKET SIZE, BY HOMECARE, 2025-2030 (USD MILLION)
TABLE 127. BRAZIL C1 ESTERASE INHIBITORS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 128. BRAZIL C1 ESTERASE INHIBITORS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 129. ARGENTINA C1 ESTERASE INHIBITORS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 130. ARGENTINA C1 ESTERASE INHIBITORS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 131. ARGENTINA C1 ESTERASE INHIBITORS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 132. ARGENTINA C1 ESTERASE INHIBITORS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 133. ARGENTINA C1 ESTERASE INHIBITORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 134. ARGENTINA C1 ESTERASE INHIBITORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 135. ARGENTINA C1 ESTERASE INHIBITORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 136. ARGENTINA C1 ESTERASE INHIBITORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 137. ARGENTINA C1 ESTERASE INHIBITORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 138. ARGENTINA C1 ESTERASE INHIBITORS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 139. ARGENTINA C1 ESTERASE INHIBITORS MARKET SIZE, BY HOMECARE, 2018-2024 (USD MILLION)
TABLE 140. ARGENTINA C1 ESTERASE INHIBITORS MARKET SIZE, BY HOMECARE, 2025-2030 (USD MILLION)
TABLE 141. ARGENTINA C1 ESTERASE INHIBITORS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 142. ARGENTINA C1 ESTERASE INHIBITORS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 143. EUROPE, MIDDLE EAST & AFRICA C1 ESTERASE INHIBITORS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 144. EUROPE, MIDDLE EAST & AFRICA C1 ESTERASE INHIBITORS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 145. EUROPE, MIDDLE EAST & AFRICA C1 ESTERASE INHIBITORS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 146. EUROPE, MIDDLE EAST & AFRICA C1 ESTERASE INHIBITORS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 147. EUROPE, MIDDLE EAST & AFRICA C1 ESTERASE INHIBITORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 148. EUROPE, MIDDLE EAST & AFRICA C1 ESTERASE INHIBITORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 149. EUROPE, MIDDLE EAST & AFRICA C1 ESTERASE INHIBITORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 150. EUROPE, MIDDLE EAST & AFRICA C1 ESTERASE INHIBITORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA C1 ESTERASE INHIBITORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 152. EUROPE, MIDDLE EAST & AFRICA C1 ESTERASE INHIBITORS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 153. EUROPE, MIDDLE EAST & AFRICA C1 ESTERASE INHIBITORS MARKET SIZE, BY HOMECARE, 2018-2024 (USD MILLION)
TABLE 154. EUROPE, MIDDLE EAST & AFRICA C1 ESTERASE INHIBITORS MARKET SIZE, BY HOMECARE, 2025-2030 (USD MILLION)
TABLE 155. EUROPE, MIDDLE EAST & AFRICA C1 ESTERASE INHIBITORS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 156. EUROPE, MIDDLE EAST & AFRICA C1 ESTERASE INHIBITORS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 157. EUROPE, MIDDLE EAST & AFRICA C1 ESTERASE INHIBITORS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 158. EUROPE, MIDDLE EAST & AFRICA C1 ESTERASE INHIBITORS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 159. UNITED KINGDOM C1 ESTERASE INHIBITORS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 160. UNITED KINGDOM C1 ESTERASE INHIBITORS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 161. UNITED KINGDOM C1 ESTERASE INHIBITORS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 162. UNITED KINGDOM C1 ESTERASE INHIBITORS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 163. UNITED KINGDOM C1 ESTERASE INHIBITORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 164. UNITED KINGDOM C1 ESTERASE INHIBITORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 165. UNITED KINGDOM C1 ESTERASE INHIBITORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 166. UNITED KINGDOM C1 ESTERASE INHIBITORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 167. UNITED KINGDOM C1 ESTERASE INHIBITORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 168. UNITED KINGDOM C1 ESTERASE INHIBITORS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 169. UNITED KINGDOM C1 ESTERASE INHIBITORS MARKET SIZE, BY HOMECARE, 2018-2024 (USD MILLION)
TABLE 170. UNITED KINGDOM C1 ESTERASE INHIBITORS MARKET SIZE, BY HOMECARE, 2025-2030 (USD MILLION)
TABLE 171. UNITED KINGDOM C1 ESTERASE INHIBITORS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 172. UNITED KINGDOM C1 ESTERASE INHIBITORS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 173. GERMANY C1 ESTERASE INHIBITORS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 174. GERMANY C1 ESTERASE INHIBITORS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 175. GERMANY C1 ESTERASE INHIBITORS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 176. GERMANY C1 ESTERASE INHIBITORS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 177. GERMANY C1 ESTERASE INHIBITORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 178. GERMANY C1 ESTERASE INHIBITORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 179. GERMANY C1 ESTERASE INHIBITORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 180. GERMANY C1 ESTERASE INHIBITORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 181. GERMANY C1 ESTERASE INHIBITORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 182. GERMANY C1 ESTERASE INHIBITORS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 183. GERMANY C1 ESTERASE INHIBITORS MARKET SIZE, BY HOMECARE, 2018-2024 (USD MILLION)
TABLE 184. GERMANY C1 ESTERASE INHIBITORS MARKET SIZE, BY HOMECARE, 2025-2030 (USD MILLION)
TABLE 185. GERMANY C1 ESTERASE INHIBITORS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 186. GERMANY C1 ESTERASE INHIBITORS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 187. FRANCE C1 ESTERASE INHIBITORS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 188. FRANCE C1 ESTERASE INHIBITORS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 189. FRANCE C1 ESTERASE INHIBITORS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 190. FRANCE C1 ESTERASE INHIBITORS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 191. FRANCE C1 ESTERASE INHIBITORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 192. FRANCE C1 ESTERASE INHIBITORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 193. FRANCE C1 ESTERASE INHIBITORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 194. FRANCE C1 ESTERASE INHIBITORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 195. FRANCE C1 ESTERASE INHIBITORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 196. FRANCE C1 ESTERASE INHIBITORS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 197. FRANCE C1 ESTERASE INHIBITORS MARKET SIZE, BY HOMECARE, 2018-2024 (USD MILLION)
TABLE 198. FRANCE C1 ESTERASE INHIBITORS MARKET SIZE, BY HOMECARE, 2025-2030 (USD MILLION)
TABLE 199. FRANCE C1 ESTERASE INHIBITORS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 200. FRANCE C1 ESTERASE INHIBITORS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 201. RUSSIA C1 ESTERASE INHIBITORS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 202. RUSSIA C1 ESTERASE INHIBITORS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 203. RUSSIA C1 ESTERASE INHIBITORS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 204. RUSSIA C1 ESTERASE INHIBITORS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 205. RUSSIA C1 ESTERASE INHIBITORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 206. RUSSIA C1 ESTERASE INHIBITORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 207. RUSSIA C1 ESTERASE INHIBITORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 208. RUSSIA C1 ESTERASE INHIBITORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 209. RUSSIA C1 ESTERASE INHIBITORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 210. RUSSIA C1 ESTERASE INHIBITORS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 211. RUSSIA C1 ESTERASE INHIBITORS MARKET SIZE, BY HOMECARE, 2018-2024 (USD MILLION)
TABLE 212. RUSSIA C1 ESTERASE INHIBITORS MARKET SIZE, BY HOMECARE, 2025-2030 (USD MILLION)
TABLE 213. RUSSIA C1 ESTERASE INHIBITORS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 214. RUSSIA C1 ESTERASE INHIBITORS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 215. ITALY C1 ESTERASE INHIBITORS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 216. ITALY C1 ESTERASE INHIBITORS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 217. ITALY C1 ESTERASE INHIBITORS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 218. ITALY C1 ESTERASE INHIBITORS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 219. ITALY C1 ESTERASE INHIBITORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 220. ITALY C1 ESTERASE INHIBITORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 221. ITALY C1 ESTERASE INHIBITORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 222. ITALY C1 ESTERASE INHIBITORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 223. ITALY C1 ESTERASE INHIBITORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 224. ITALY C1 ESTERASE INHIBITORS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 225. ITALY C1 ESTERASE INHIBITORS MARKET SIZE, BY HOMECARE, 2018-2024 (USD MILLION)
TABLE 226. ITALY C1 ESTERASE INHIBITORS MARKET SIZE, BY HOMECARE, 2025-2030 (USD MILLION)
TABLE 227. ITALY C1 ESTERASE INHIBITORS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 228. ITALY C1 ESTERASE INHIBITORS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 229. SPAIN C1 ESTERASE INHIBITORS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 230. SPAIN C1 ESTERASE INHIBITORS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 231. SPAIN C1 ESTERASE INHIBITORS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 232. SPAIN C1 ESTERASE INHIBITORS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 233. SPAIN C1 ESTERASE INHIBITORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 234. SPAIN C1 ESTERASE INHIBITORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 235. SPAIN C1 ESTERASE INHIBITORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 236. SPAIN C1 ESTERASE INHIBITORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 237. SPAIN C1 ESTERASE INHIBITORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 238. SPAIN C1 ESTERASE INHIBITORS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 239. SPAIN C1 ESTERASE INHIBITORS MARKET SIZE, BY HOMECARE, 2018-2024 (USD MILLION)
TABLE 240. SPAIN C1 ESTERASE INHIBITORS MARKET SIZE, BY HOMECARE, 2025-2030 (USD MILLION)
TABLE 241. SPAIN C1 ESTERASE INHIBITORS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 242. SPAIN C1 ESTERASE INHIBITORS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 243. UNITED ARAB EMIRATES C1 ESTERASE INHIBITORS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 244. UNITED ARAB EMIRATES C1 ESTERASE INHIBITORS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 245. UNITED ARAB EMIRATES C1 ESTERASE INHIBITORS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 246. UNITED ARAB EMIRATES C1 ESTERASE INHIBITORS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 247. UNITED ARAB EMIRATES C1 ESTERASE INHIBITORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 248. UNITED ARAB EMIRATES C1 ESTERASE INHIBITORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 249. UNITED ARAB EMIRATES C1 ESTERASE INHIBITORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 250. UNITED ARAB EMIRATES C1 ESTERASE INHIBITORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 251. UNITED ARAB EMIRATES C1 ESTERASE INHIBITORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 252. UNITED ARAB EMIRATES C1 ESTERASE INHIBITORS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 253. UNITED ARAB EMIRATES C1 ESTERASE INHIBITORS MARKET SIZE, BY HOMECARE, 2018-2024 (USD MILLION)
TABLE 254. UNITED ARAB EMIRATES C1 ESTERASE INHIBITORS MARKET SIZE, BY HOMECARE, 2025-2030 (USD MILLION)
TABLE 255. UNITED ARAB EMIRATES C1 ESTERASE INHIBITORS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 256. UNITED ARAB EMIRATES C1 ESTERASE INHIBITORS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 257. SAUDI ARABIA C1 ESTERASE INHIBITORS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 258. SAUDI ARABIA C1 ESTERASE INHIBITORS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 259. SAUDI ARABIA C1 ESTERASE INHIBITORS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 260. SAUDI ARABIA C1 ESTERASE INHIBITORS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 261. SAUDI ARABIA C1 ESTERASE INHIBITORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 262. SAUDI ARABIA C1 ESTERASE INHIBITORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 263. SAUDI ARABIA C1 ESTERASE INHIBITORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 264. SAUDI ARABIA C1 ESTERASE INHIBITORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 265. SAUDI ARABIA C1 ESTERASE INHIBITORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 266. SAUDI ARABIA C1 ESTERASE INHIBITORS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 267. SAUDI ARABIA C1 ESTERASE INHIBITORS MARKET SIZE, BY HOMECARE, 2018-2024 (USD MILLION)
TABLE 268. SAUDI ARABIA C1 ESTERASE INHIBITORS MARKET SIZE, BY HOMECARE, 2025-2030 (USD MILLION)
TABLE 269. SAUDI ARABIA C1 ESTERASE INHIBITORS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 270. SAUDI ARABIA C1 ESTERASE INHIBITORS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 271. SOUTH AFRICA C1 ESTERASE INHIBITORS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 272. SOUTH AFRICA C1 ESTERASE INHIBITORS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 273. SOUTH AFRICA C1 ESTERASE INHIBITORS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 274. SOUTH AFRICA C1 ESTERASE INHIBITORS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 275. SOUTH AFRICA C1 ESTERASE INHIBITORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 276. SOUTH AFRICA C1 ESTERASE INHIBITORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 277. SOUTH AFRICA C1 ESTERASE INHIBITORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 278. SOUTH AFRICA C1 ESTERASE INHIBITORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 279. SOUTH AFRICA C1 ESTERASE INHIBITORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 280. SOUTH AFRICA C1 ESTERASE INHIBITORS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 281. SOUTH AFRICA C1 ESTERASE INHIBITORS MARKET SIZE, BY HOMECARE, 2018-2024 (USD MILLION)
TABLE 282. SOUTH AFRICA C1 ESTERASE INHIBITORS MARKET SIZE, BY HOMECARE, 2025-2030 (USD MILLION)
TABLE 283. SOUTH AFRICA C1 ESTERASE INHIBITORS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 284. SOUTH AFRICA C1 ESTERASE INHIBITORS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 285. DENMARK C1 ESTERASE INHIBITORS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 286. DENMARK C1 ESTERASE INHIBITORS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 287. DENMARK C1 ESTERASE INHIBITORS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 288. DENMARK C1 ESTERASE INHIBITORS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 289. DENMARK C1 ESTERASE INHIBITORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 290. DENMARK C1 ESTERASE INHIBITORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 291. DENMARK C1 ESTERASE INHIBITORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 292. DENMARK C1 ESTERASE INHIBITORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 293. DENMARK C1 ESTERASE INHIBITORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 294. DENMARK C1 ESTERASE INHIBITORS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 295. DENMARK C1 ESTERASE INHIBITORS MARKET SIZE, BY HOMECARE, 2018-2024 (USD MILLION)
TABLE 296. DENMARK C1 ESTERASE INHIBITORS MARKET SIZE, BY HOMECARE, 2025-2030 (USD MILLION)
TABLE 297. DENMARK C1 ESTERASE INHIBITORS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 298. DENMARK C1 ESTERASE INHIBITORS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 299. NETHERLANDS C1 ESTERASE INHIBITORS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 300. NETHERLANDS C1 ESTERASE INHIBITORS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 301. NETHERLANDS C1 ESTERASE INHIBITORS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 302. NETHERLANDS C1 ESTERASE INHIBITORS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 303. NETHERLANDS C1 ESTERASE INHIBITORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 304. NETHERLANDS C1 ESTERASE INHIBITORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 305. NETHERLANDS C1 ESTERASE INHIBITORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 306. NETHERLANDS C1 ESTERASE INHIBITORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 307. NETHERLANDS C1 ESTERASE INHIBITORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 308. NETHERLANDS C1 ESTERASE INHIBITORS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 309. NETHERLANDS C1 ESTERASE INHIBITORS MARKET SIZE, BY HOMECARE, 2018-2024 (USD MILLION)
TABLE 310. NETHERLANDS C1 ESTERASE INHIBITORS MARKET SIZE, BY HOMECARE, 2025-2030 (USD MILLION)
TABLE 311. NETHERLANDS C1 ESTERASE INHIBITORS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 312. NETHERLANDS C1 ESTERASE INHIBITORS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 313. QATAR C1 ESTERASE INHIBITORS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 314. QATAR C1 ESTERASE INHIBITORS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 315. QATAR C1 ESTERASE INHIBITORS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 316. QATAR C1 ESTERASE INHIBITORS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 317. QATAR C1 ESTERASE INHIBITORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 318. QATAR C1 ESTERASE INHIBITORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 319. QATAR C1 ESTERASE INHIBITORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 320. QATAR C1 ESTERASE INHIBITORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 321. QATAR C1 ESTERASE INHIBITORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 322. QATAR C1 ESTERASE INHIBITORS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 323. QATAR C1 ESTERASE INHIBITORS MARKET SIZE, BY HOMECARE, 2018-2024 (USD MILLION)
TABLE 324. QATAR C1 ESTERASE INHIBITORS MARKET SIZE, BY HOMECARE, 2025-2030 (USD MILLION)
TABLE 325. QATAR C1 ESTERASE INHIBITORS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 326. QATAR C1 ESTERASE INHIBITORS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 327. FINLAND C1 ESTERASE INHIBITORS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 328. FINLAND C1 ESTERASE INHIBITORS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 329. FINLAND C1 ESTERASE INHIBITORS MARKET SIZE, BY PRODU
Samples
LOADING...
Companies Mentioned
The companies profiled in this C1 Esterase Inhibitors market report include:- Takeda Pharmaceutical Company Limited
- CSL Limited
- Octapharma AG
- Pharming Group N.V.
- Kamada Ltd.
- Kedrion S.p.A.
